After the COVID-19 outbreak, one of the most widely used vaccines was Covishield, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of India. As countries around the world ...

FILE PHOTO: A man displays a vial AstraZeneca's COVISHIELD vaccine as the country receives its first batch of coronavirus disease (COVID-19) vaccines under COVAX scheme, in Accra KAMPALA (Reuters) - ...

In a recent development, AstraZeneca has acknowledged a potential rare side effect associated with its COVID-19 vaccine, including Covishield, the version widely used in India. This admission, made in ...

Covishield and Covaxin are the two vaccines used in the majority of the Indian population. The four permutations for a booster dose evaluated in this study are primary immunization with Covishield ...

To the unversed, AstraZeneca which developed Covishield to fight the coronavirus pandemic recently admitted that its vaccine may cause side effects and result to a rare condition termed TTS ...

The study was conducted on the participants who had received the booster dose of the Covishield vaccination. The investigation came to the conclusion that a fourth dose of the vaccination wasn't ...

While Malhotra has been leading international calls for the suspension of mRNA COVID-19 vaccines, he insists that the Oxford-AstraZeneca's jab is even 'worse' in terms of cardiovascular effects, heart ...

Amid mounting concerns regarding Covishield’s safety and the acknowledgment of potential adverse effects by its maker UK giant AstraZeneca, public unease is on the rise, with calls for ...

NEW DELHI: A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and ...

A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and published in The ...

A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, study.(Representational image: IE) A booster dose of Covishield ...